Urinary L-FABP identified approximately 60% more patients with increased L-FABP but without creatinine-defined AKI (tubular damage without excretory dysfunction)—an indicator of subclinical AKI—than those with creatinine-defined AKI status alone. This evidence concerns the gene FABP1 and acute kidney injury.